Atossa Therapeutics (ATOS) Prepaid Assets (2011 - 2026)
Atossa Therapeutics (ATOS) posted quarterly Prepaid Assets of $1.8 million for Q1 2026, up 26.96% year-over-year from $1.4 million in Q1 2025, and up 61.97% quarter-over-quarter from $1.1 million in Q4 2025.
Atossa Therapeutics (ATOS) Prepaid Assets (2011 - 2026) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Prepaid Assets for 16 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 26.96% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (up 26.96% YoY), while the FY2025 annual figure was $1.1 million, down 3.18% from the prior year.
- Prepaid Assets grew to $1.8 million in Q1 2026 per ATOS's latest filing, from $1.1 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $5.3 million in Q2 2022 and bottomed at $7000.0 in Q3 2023.
- Historically, Prepaid Assets has averaged $1.5 million across 5 years, with a median of $1.1 million in 2025.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 55586.4% — and 2023, when it slumped 99.86%.
- Atossa Therapeutics' Prepaid Assets stood at $1.2 million in 2022, then soared by 79.12% to $2.2 million in 2023, then tumbled by 46.11% to $1.2 million in 2024, then fell by 3.18% to $1.1 million in 2025, then surged by 61.97% to $1.8 million in 2026.
- Business Quant data shows ATOS's Prepaid Assets at $1.8 million in Q1 2026, $1.1 million in Q4 2025, and $580000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Atossa Therapeutics | 22.63 Mn | 22.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.79 Mn |
| Mar 31, 2026 | 1.83 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 580,000.00 |
| Jun 30, 2025 | 1.08 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 950,000.00 |
| Jun 30, 2024 | 987,000.00 |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 2.16 Mn |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | 141,000.00 |
| Mar 31, 2023 | 520,000.00 |
| Dec 31, 2022 | 1.21 Mn |
| Sep 30, 2022 | 5.11 Mn |
| Jun 30, 2022 | 5.30 Mn |
| Mar 31, 2022 | 613,000.00 |
| Dec 31, 2021 | 1.19 Mn |
| Sep 30, 2021 | 9,171.00 |